Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3448890 Title: ANTICORPS BISPÉCIFIQUES CIBLANT EGFR ET HER2

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177245040
WO application number:
EP2017060280
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3448890
WO publication number:
WO2017186950
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
28/04/2017
Grant date:
19/07/2023
EP publication date:
06/03/2019
WO publication date:
02/11/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/07/2023
EP B1 publication date:
19/07/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/04/2024
Expiration date (if granted and all annual fees paid):
28/04/2037

Applicant

1

Name:
Biomunex Pharmaceuticals
Legal Form:
From:
19/07/2023
Address:
113 rue de la Tour, 75116 Paris, France (FR)
To:

2

Name:
INSERM (Institut National de la Santé et de la Recherche Médicale)
Legal Form:
From:
19/07/2023
Address:
101, rue de Tolbiac, 75013 Paris, France (FR)
To:

3

Name:
Université de Montpellier
Legal Form:
From:
19/07/2023
Address:
163, rue Auguste Broussonnet, 34090 Montpellier, France (FR)
To:

4

Name:
Institut Régional du Cancer de Montpellier (ICM)
Legal Form:
From:
19/07/2023
Address:
208 Rue des Apothicaires Parc Euromédecine, 34298 Montpellier Cedex 5, France (FR)
To:

Inventor

1

Name:
ZHUKOVSKY, Eugene
Legal Form:
Address:
75016 Paris, France (FR)

2

Name:
LEGER, Olivier
Legal Form:
Address:
74800 Saint Sixt, France (FR)

3

Name:
GERARD, Pierre-Emmanuel
Legal Form:
Address:
75116 Paris, France (FR)

4

Name:
PELEGRIN, André
Legal Form:
Address:
75013 Paris, France (FR)

5

Name:
LARBOURET, Christel
Legal Form:
Address:
75013 Paris, France (FR)

Priority

Priority patent number:
16305496
Priority date:
28/04/2016
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
C07K 16/28; C07K 16/46;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2023/14
Publication date:
22/08/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2024/23
Publication date:
27/12/2024
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202329
Publication date:
19/07/2023
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type